Jeffrey S. Ramsay

Davis Polk also advised the initial purchasers in connection with a concurrent Rule 144A offering by NCL Corporation Ltd. (“NCLC”) of $862.5 million aggregate principal amount of its 6…

Davis Polk advised the joint book-running managers, in connection with an SEC-registered offering by Zoetis Inc. of $750 million aggregate principal amount of its 2.000% senior notes due…

Davis Polk advised VF Corporation in connection with an SEC-registered debt shelf takedown of $1 billion aggregate principal amount of its 2.050% senior notes due 2022, $750 million…

Davis Polk advised the representatives of the several underwriters in connection with the registered offering by DXC Technology Company of $500 million aggregate principal amount of 4.000%…

Davis Polk advised the representative of the initial purchasers on a Rule 144A/Regulation S offering by YUM! Brands, Inc. of $600 million aggregate principal amount of 7.75% senior…

Davis Polk advised the representatives of the several initial purchasers, in a Rule 144A/Regulation S offering by Huntington Ingalls Industries, Inc. of $500 million aggregate…

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of $1.5 billion aggregate principal amount of 2.400% senior notes due…

Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of its 3.625% senior notes due 2030. The notes are guaranteed by…

Davis Polk advised VF Corporation in connection with an SEC-registered debt shelf takedown of €500 million aggregate principal amount of its 0.250% senior notes due 2028 (the “2028 notes”)…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,300,000 shares of its common stock. The common stock is listed on the…